‘An IPO May Not Have Delivered Fair Value’ – Biocon Biologics CEO Tambe Sets Out Merger Rationale

Integration With Biocon Ltd Is ‘The Next Chapter In Our Evolution’

Shreehas Tambe talks to Generics Bulletin for an exclusive Q&A (Biocon)

More from Strategy

More from Business